# MSC-Exosome Therapy for Frontotemporal Dementia

> **NCT07638813** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **Ruijin Hospital** · enrollment: 33 (estimated)

## Conditions studied

- Frontotemporal Dementia

## Interventions

- **BIOLOGICAL:** Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes （Low-Dose）
- **BIOLOGICAL:** Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes （High-Dose）
- **OTHER:** Placebo Comparator (0.9% NaCl)

## Key facts

- **NCT ID:** NCT07638813
- **Lead sponsor:** Ruijin Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-01
- **Primary completion:** 2027-10-31
- **Final completion:** 2027-10-31
- **Target enrollment:** 33 (ESTIMATED)
- **Last updated:** 2026-07-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07638813

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07638813, "MSC-Exosome Therapy for Frontotemporal Dementia". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07638813. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*